01 Home Enteral Nutrition Is Expanding Beyond Hospital-Based Care The clinical nutrition market trends show that growing demand for long-term nutritional support is shifting enteral feeding from hospitals toward home-based care. This transition is supported by dedicated ESPEN guidance for home enteral nutrition, covering patients who require nutritional support outside acute-care settings. The outcome is greater demand for enteral formulas, feeding equipment, and home-based nutrition services.
02 Micronutrient Management Is Gaining Greater Clinical Attention The clinical nutrition market trends show that greater focus on nutritional adequacy is shifting clinical care beyond calories and macronutrients toward structured vitamin, mineral, and trace-element management. This transition is reflected in ESPEN's dedicated micronutrient guidance for clinical nutrition, which addresses practical considerations for micronutrient provision. The outcome is stronger demand for specialized micronutrient assessment and supplementation within clinical nutrition programs.
01 Aging Population and Increasing Surgical Procedures Drive Market An aging global population is expanding the need for specialized nutritional support because older adults face greater risks of inadequate intake during illness, hospitalization, and recovery. UN DESA projects that the global population aged 65 years and older will exceed 1.6 billion by 2050, creating a larger patient base requiring nutritional management. Hospitals and long-term care facilities can use oral nutritional supplements and specialized formulations to support older patients with reduced appetite or recovery needs. This demographic shift strengthens demand for clinical nutrition products.A high volume of surgical procedures is creating demand for nutritional support before and after treatment, particularly among patients with prolonged recovery or inadequate oral intake. WHO reports that more than 313 million surgical procedures are performed globally each year, highlighting the scale of the potential clinical nutrition requirement. Perioperative nutrition products can support patients who require additional energy and protein during recovery, while hospitals can integrate these products into surgical care pathways. This sustained procedure volume supports demand for specialized clinical nutrition solutions.
01 High Product Costs and Patient-Specific Formulation Complexity Restrain Clinical Nutrition Market Expansion High costs of specialized clinical nutrition products increase the financial burden on patients and healthcare providers, particularly for long-term nutritional support. Higher product and delivery expenses can limit affordability and restrict access in cost-sensitive healthcare settings, slowing wider adoption.Complex patient-specific formulations require nutritional compositions to be adjusted according to disease conditions, nutrient requirements, and patient tolerance. This customization increases preparation, monitoring, and clinical management requirements, which can raise treatment complexity and limit efficient adoption across healthcare facilities.
01 Disease-Specific and Sarcopenia-Focused Nutrition Create New Market Opportunities Medical-food manufacturers, clinical nutrition companies, and healthcare providers can develop specialized formulas for kidney disease, diabetes, gastrointestinal disorders, and other conditions. Companies such as Nestlé Health Science and Abbott can expand their clinical nutrition portfolios through condition-specific products, creating revenue from specialized formulas, hospital contracts, and premium medical-nutrition programs.Clinical nutrition manufacturers, medical-food developers, and rehabilitation providers can develop protein-rich formulas designed for patients experiencing muscle loss and reduced physical function. Companies such as Abbott and Nestlé Health Science can extend existing nutrition portfolios into sarcopenia-focused products and recovery programs, creating revenue through specialized formulas, clinical partnerships, and rehabilitation-linked nutrition services.
01 Parenteral Nutrition Supply Disruptions and Limited Access to Specialized Nutrition Care Hinder Clinical Nutrition Market Growth Parenteral nutrition supply disruptions can interrupt the availability of essential formulations and force healthcare providers to modify treatment plans or rely on alternatives. In September 2026, the FDA reported actions to maintain access to neonatal starter parenteral nutrition after two outsourcing facilities planned closures, highlighting the vulnerability of supply for critical nutrition products.Limited access to specialized nutrition care restricts the identification, prescription, administration, and monitoring of clinical nutrition therapies, particularly in lower-resource healthcare settings. WHO highlights shortages of trained healthcare professionals and gaps in nutrition-care capacity as continuing barriers to effective nutritional support, limiting adoption of specialized clinical nutrition services.
June 2026 Nestlé Health Science launched new high-protein clinical nutrition products for patients requiring medical nutrition support during recovery and healthy aging. The formulations help address disease-related malnutrition and improve nutritional outcomes.
May 2026 Danone completed the acquisition of The Akkermansia Company, strengthening its clinical nutrition and microbiome science portfolio. The acquisition expands Danone's capabilities in developing next-generation nutritional solutions for gut and metabolic health.
February 2026 Abbott expanded its therapeutic nutrition portfolio by introducing specialized nutritional products for people with diabetes, cancer, and age-related muscle loss. The launch supports personalized clinical nutrition strategies.
October 2025 Fresenius Kabi introduced advanced enteral nutrition formulations with optimized protein and micronutrient profiles to support patients in hospitals and long-term care settings.